Sun Pharma

Sun Pharma is recalling 747 bottles of generic diabetes drug due to higher levels of NDMA while Strides Pharma is recalling 11,280…

oth the companies are recalling metformin because it may contain N-nitrosodimethylamine (NDMA) above the acceptable intake limit.

It is indicated for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies…

Two applications each of Micro Laboratories and Sun Pharma have been deferred by the authority

Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg while Sun Pharma is recalling 3,516 bottles of Clonazepam…

The cost of acquisition is about $8.2 million

The company's focus is also on supply chain protection and ensuring optimum utilisation of its factories informed the MD of the…

ILUMYA is one of the key specialty products of Sun Pharma and it was approved by US FDA in March 2018 while the European…

ILUMYA (tildrakizumab) is an US FDA approved innovative IL-23p19 monoclonal antibody used for the treatment of adults with…

Analyses of long-term data confirm that the continued and clinically meaningful results of ODOMZO (sonidegib) in people with…